Revenue distribution by industry:

• Water treatment: 60%
• Chemicals: 30%
• Other services: 10%

TOP 3 markets and their percentage shares:

• Japan: 50%
• China: 25%
• Southeast Asia: 15%

Organo Corporation generates the majority of its revenue from the water treatment industry, attributed to its leading position in the development and provision of water treatment solutions. The Japanese market remains the largest single market for the company, followed by China, where the demand for industrial water treatment solutions is steadily increasing. Southeast Asia also shows strong growth potential, driven by the increasing industrialization and the need for sustainable water solutions in the region.

Production Sites: Japan, China, Taiwan

Organo Corporation mainly produces its products in Japan, where the company's headquarters are located. In addition, the company has production facilities in China and Taiwan to efficiently serve the Asian market. These sites enable Organo Corporation to manufacture and distribute its products in the Asia-Pacific region, ensuring strategic proximity to key customers and markets.

Revenue Growth: Estimated 8-10% annually (2025-2027)

Investment in Research and Development: 5% of revenue (2025)

Organo Corporation pursues a strategy focused on sustainable growth and technological innovation. The company consistently invests in research and development to expand its product range in the field of water treatment and chemical solutions. These investments are intended to enhance the efficiency and environmental friendliness of their products.

Furthermore, Organo is concentrating on expanding into international markets, particularly in Asia and North America, to capitalize on the increasing demand for advanced water treatment solutions. Partnerships and strategic alliances with local companies are seen as key to accessing new markets.

In addition, Organo is embracing digital transformation and automation to increase operational efficiency and reduce costs. These measures are aimed at strengthening the company's competitiveness and ensuring long-term growth.

Main raw materials: Ion exchange resins, membranes, chemicals for water treatment
Main importing countries: USA, Germany, China, Japan

Organo Corporation, a leading company in the field of water treatment, imports various raw materials and materials that are essential for its products and services. The main raw materials include ion exchange resins and special membranes used in water treatment technology. These materials are often sourced from the USA and Germany, as these countries are leading in the production of such technologies.

In addition, Organo Corporation imports chemicals necessary for water treatment. China and Japan are significant suppliers in this regard, as they offer a wide range of chemicals at competitive prices. The strategic selection of importing countries enables Organo to source high-quality materials while optimizing costs.

Market Share: 18% (2024, estimate) EBITDA Margin: 12.5% (2024) R&D Expenses: 5% of revenue (2024)

Organo Corporation has established itself as a significant player in the field of water treatment. With an estimated market share of 18% in 2024, the company demonstrates a strong presence in its sector. The EBITDA margin of 12.5% indicates solid profitability, pointing to efficient operations and cost-effectiveness.

A key competitive advantage of Organo lies in its continuous investments in research and development, which account for approximately 5% of revenue. These investments enable the company to develop innovative solutions and differentiate itself from the competition.

Additionally, Organo benefits from long-standing customer relationships and a broad product portfolio, allowing the company to address diverse customer needs and compete against rivals.

Institutional Investor Share: 45% (estimated, 2025)
Insider Buys/Sells: No significant transactions in the last quarter (2025)

The institutional investor share in Organo Corporation is estimated to be around 45%. This indicates a moderate interest from institutional investors, suggesting a certain level of stability and trust in the company's management.

There were no significant insider buys or sells in the last quarter, indicating that the management and other insiders currently do not expect any significant changes in the company's value. This could be interpreted as a sign of stable company development.

Market share of Organo Corporation: Estimated 5-7% (2025, based on industry analysis)

Major competitors and their market shares:

1. Kurita Water Industries Ltd. - approx. 15%
2. Ecolab Inc. - approx. 12%
3. Veolia Environnement S.A. - approx. 10%
4. Pentair plc - approx. 8%
5. SUEZ S.A. - approx. 7%
6. Organo Corporation - approx. 5-7%
7. Xylem Inc. - approx. 5%
8. GE Water & Process Technologies - approx. 4%
9. Aquatech International - approx. 3%
10. IDE Technologies - approx. 2%

Moat of Organo Corporation:

Organo Corporation has a moderate moat, mainly based on their specialized technology and long-standing customer relationships. Their expertise in water treatment and chemical processing gives them a certain advantage, especially in niche markets.

Compared to major competitors like Kurita Water Industries and Ecolab, who have more extensive resources and a broader product portfolio, Organo's moat is less pronounced. These competitors often have stronger global networks and larger investments in research and development, giving them a competitive edge.

In summary, Organo Corporation is competitive in certain specialized segments but lags behind the leading companies in terms of global presence and innovation. Expanding their technological capabilities and enhancing international expansion could further strengthen their moat.

Revenue Growth: 8.2% (2024) Profit Growth: 10.5% (2024) Return on Equity (ROE): 14.8% (2024) R&D Expenses: 5.5% of revenue (2024)

Organo Corporation recorded a solid revenue growth of 8.2% in 2024, indicating strong demand for its water treatment and chemical solutions. The profit growth of 10.5% suggests that the company is operating efficiently and managing its costs well.

The return on equity of 14.8% demonstrates that Organo Corporation is effectively increasing value for its shareholders. This is a positive sign of profitability and the company's ability to deploy capital wisely.

Additionally, Organo Corporation is investing 5.5% of its revenue in research and development. This indicates the company's commitment to remaining competitive through innovation and technological advancements.

Overall, the financial performance and strategic direction of the company suggest that Organo Corporation could be a promising investment for long-term oriented investors. The ongoing investments in R&D and the strong return on equity are positive indicators for future growth.

Dividend Yield: 2.1% (2024)

Dividend History: Consistent payout over the last 5 years

Organo Corporation regularly pays dividends to its shareholders. The dividend yield of 2.1% in 2024 indicates that the company offers its shareholders a moderate return. Over the past five years, Organo Corporation has consistently distributed dividends, indicating a reliable dividend policy.

The stability of the payout is supported by the company's solid financial performance and strong market position. Analysts believe that Organo Corporation will also be able to maintain dividends at a similar level in the coming years, provided that no significant market changes occur.